Price target
2.560.00 0.00%
The 2 analysts offering 1 year price forecasts for MDG1 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to MDG1 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
MDG1 EPS for the last quarter is −0.34 CHF despite the estimation of −0.45 CHF. In the next quarter EPS is expected to reach −0.27 CHF. Track more of MEDIGENE financials and stay on top of what is up with the company.
In the next quarter MEDIGENE revenue is expected to reach 4.08 M CHF. Check out MEDIGENE revenue and earnings and make informed decisions.
According to analysts, MDG1 price target is 2.56 CHF with a max estimate of 2.93 CHF and a min estimate of 2.18 CHF. Check if this forecast comes true in a year, meanwhile keep track of the current situation with MDG1 news and stock market news.